{{Rsnum
|rsid=4130590
|Gene=GARNL3
|Chromosome=9
|position=127345685
|Orientation=plus
|GMAF=0.3994
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=GARNL3
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 17.7 | 46.9 | 35.4
| HCB | 15.3 | 56.9 | 27.7
| JPT | 27.4 | 49.6 | 23.0
| YRI | 15.0 | 45.6 | 39.5
| ASW | 5.3 | 45.6 | 49.1
| CHB | 15.3 | 56.9 | 27.7
| CHD | 25.7 | 38.5 | 35.8
| GIH | 17.8 | 48.5 | 33.7
| LWK | 3.6 | 37.3 | 59.1
| MEX | 13.8 | 46.6 | 39.7
| MKK | 19.2 | 46.8 | 34.0
| TSI | 17.6 | 51.0 | 31.4
| HapMapRevision=28
}}{{GWAS Summary
|SNP=rs4130590
|PubMedID=18711365
|Condition=Bipolar disorder
|Gene=NR
|Risk Allele=
|pValue=3.00E-006
|OR=1.16
|95CI=
|OA=1
}}

{{PharmGKB
|RSID=rs4130590
|Name_s=
|Gene_s=GARNL3
|Feature=
|Evidence=PubMed ID:18711365; Web Resource:http://www.genome.gov/gwastudies/
|Annotation=GWAS results: Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder (Initial Sample Size: 1,098 cases, 1,267 controls; Replication Sample Size: 4,387 cases, 6,209 controls). This variant is associated with Bipolar disorder.
|Drugs=
|Drug Classes=
|Diseases=Bipolar Disorder
|Curation Level=Non-Curated
|PharmGKB Accession ID=PA162356409
}}

{{PMID Auto
|PMID=20369022
|Title=Candidate causal regulatory effects by integration of expression QTLs with complex trait genetic associations.
|OA=1
}}

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs4130590
|overall_frequency_n=69
|overall_frequency_d=120
|overall_frequency=0.575
|n_genomes=43
|n_genomes_annotated=0
|n_haplomes=61
|n_articles=0
|n_articles_annotated=0
|in_gwas=Y
|in_pharmgkb=Y
|autoscore=2
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}